The GLP‑1 beverage market is accelerating fast, with brands innovating in hydration, protein, fibre and collagen to meet soaring consumer demand. Discover the growth forecasts, key ingredients, and ...
As more patients take GLP-1 medications, it’s common for patient questions to arise about how alcohol consumption may affect ...
Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...
These kitchen staples are nutrient-dense and easy to tolerate.
The rising use of GLP-1 weight-loss drugs is a “structural disruption” to the food and drinks sector and “not a fad”, new GlobalData research suggests. Citing research by US non-profit RAND, ...
The rise of GLP‑1 medications may accelerate long‑needed changes in the food system, pushing companies to rethink flavor, texture, portioning and even the definition of enjoyment itself, according to ...
GLP‑1 drugs are reshaping appetite, cravings and taste perception. Discover new research and what it means for food and drink ...
I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results